BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Segrelles-Calvo G, de S Araújo GR, Frases S. Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiol 2020;15:1405-13. [PMID: 33085538 DOI: 10.2217/fmb-2020-0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Katal S, Eibschutz LS, Radmard AR, Naderpour Z, Gupta A, Hejal R, Gholamrezanezhad A. Black Fungus and beyond: COVID-19 associated infections. Clinical Imaging 2022. [DOI: 10.1016/j.clinimag.2022.07.005] [Reference Citation Analysis]
2 Feldman C, Waterer G. When should corticosteroids be used for COVID-19 infection? Eur Respir J 2022;60:2103222. [PMID: 35835475 DOI: 10.1183/13993003.03222-2021] [Reference Citation Analysis]
3 Ghosh D, Dey S, Chakraborty H, Mukherjee S, Halder A, Sarkar A, Chakraborty P, Ghosh R, Sarkar J. Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India. Clinical Epidemiology and Global Health 2022;15:101013. [DOI: 10.1016/j.cegh.2022.101013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ahmed N, Mahmood MS, Ullah MA, Araf Y, Rahaman TI, Moin AT, Hosen MJ. COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies. Curr Microbiol 2022;79:127. [PMID: 35287179 DOI: 10.1007/s00284-022-02824-6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Staniszewska M, Zdrojewski T, Gizińska M, Rogalska M, Kuryk Ł, Kowalkowska A, Łukowska-chojnacka E. Tetrazole derivatives bearing benzodiazepine moiety—synthesis and action mode against virulence of Candida albicans. European Journal of Medicinal Chemistry 2022;230:114060. [DOI: 10.1016/j.ejmech.2021.114060] [Reference Citation Analysis]
6 Dornelles G, Araújo GR, Rodrigues M, Alves V, Costa RC, Abreu J, Figueiredo-carvalho MH, Almeida-paes R, Frases S. The Harris’ hawk ( Parabuteo unicinctus ) as a source of pathogenic human yeasts: a potential risk to human health. Future Microbiology. [DOI: 10.2217/fmb-2021-0166] [Reference Citation Analysis]
7 Elmokadem AH, Bayoumi D, Mansour M, Ghonim M, Saad EA, Khedr D. COVID-19-associated acute invasive fungal sinusitis: Clinical and imaging findings. J Neuroimaging 2022. [PMID: 35043509 DOI: 10.1111/jon.12967] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Basile K, Halliday C, Kok J, Chen SC. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients. JoF 2022;8:58. [DOI: 10.3390/jof8010058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Samson R, Dharne M. COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis. 3 Biotech 2022;12:6. [PMID: 34900512 DOI: 10.1007/s13205-021-03080-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Moreno-Gómez LM, Esteban-Sinovas O, García-Pérez D, García-Posadas G, Delgado-Fernández J, Paredes I. Case Report: SARS-CoV-2 Infection-Are We Redeemed? A Report of Candida Spondylodiscitis as a Late Complication. Front Med (Lausanne) 2021;8:751101. [PMID: 34901064 DOI: 10.3389/fmed.2021.751101] [Reference Citation Analysis]
11 Burchacka E, Pięta P, Łupicka-Słowik A. Recent advances in fungal serine protease inhibitors. Biomed Pharmacother 2021;146:112523. [PMID: 34902742 DOI: 10.1016/j.biopha.2021.112523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, Schwartz IS, Spec A, Ostrosky-Zeichner L, Jackson BR, Patterson TF, Pappas PG. Coronavirus Disease 2019-Associated Invasive Fungal Infection. Open Forum Infect Dis 2021;8:ofab510. [PMID: 34877364 DOI: 10.1093/ofid/ofab510] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
13 Amin A, Vartanian A, Poladian N, Voloshko A, Yegiazaryan A, Al-Kassir AL, Venketaraman V. Root Causes of Fungal Coinfections in COVID-19 Infected Patients. Infect Dis Rep 2021;13:1018-35. [PMID: 34940403 DOI: 10.3390/idr13040093] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
14 Almeida-Paes R, de Andrade IB, Ramos MLM, Rodrigues MVA, do Nascimento VA, Bernardes-Engemann AR, Frases S. Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi. Mem Inst Oswaldo Cruz 2021;116:e210207. [PMID: 34755820 DOI: 10.1590/0074-02760210207] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Kuchi Bhotla H, Balasubramanian B, Meyyazhagan A, Pushparaj K, Easwaran M, Pappusamy M, Alwin Robert A, Arumugam VA, Tsibizova V, Msaad Alfalih A, Aljowaie RM, Saravanan M, Di Renzo GC. Opportunistic mycoses in COVID-19 patients/survivors: Epidemic inside a pandemic. J Infect Public Health 2021;14:1720-6. [PMID: 34700291 DOI: 10.1016/j.jiph.2021.10.010] [Reference Citation Analysis]
16 Frías-De-León MG, Pinto-Almazán R, Hernández-Castro R, García-Salazar E, Meza-Meneses P, Rodríguez-Cerdeira C, Arenas R, Conde-Cuevas E, Acosta-Altamirano G, Martínez-Herrera E. Epidemiology of Systemic Mycoses in the COVID-19 Pandemic. J Fungi (Basel) 2021;7:556. [PMID: 34356935 DOI: 10.3390/jof7070556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]